Argan (AGX) Common Equity (2011 - 2026)

Argan has disclosed Common Equity across 16 years of filings, most recently posting $462.3 million for Q1 2026.

• Common Equity for Q1 2026 came in at $462.3 million, up 31.38% year-over-year; the trailing twelve-month figure through Jan 2026 was $462.3 million (up 31.38% YoY), and the FY2026 annual result was $462.3 million, up 31.38% from the prior year.
• Common Equity came in at $462.3 million for Q1 2026 at Argan, up from $419.7 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $462.3 million in Q1 2026 to a low of $271.7 million in Q4 2022.
• The 5-year median for Common Equity is $302.0 million (2022), against an average of $324.5 million.
• Across the five-year window, Common Equity retreated 22.31% in 2022 and soared 31.38% in 2026, its largest moves.
• Argan's Common Equity stood at $271.7 million in 2022, then climbed by 4.82% to $284.8 million in 2023, then advanced by 15.4% to $328.7 million in 2024, then gained by 27.69% to $419.7 million in 2025, then rose by 10.14% to $462.3 million in 2026.
• The last three Common Equity figures came in at $462.3 million (Q1 2026), $419.7 million (Q4 2025), and $393.2 million (Q3 2025), per Business Quant data.